Journals / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 3

Ventriculoperitoneal (VP) Shunt Survival in Patients Developing Hydrocephalus After Cranial Surgery

Pages
369–377
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall rate of shunt failure was 14.9% at a mean follow-up of 16 months.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Ventriculoperitoneal (VP) shunt insertion remains the most popular method for the treatment of hydrocephalus despite its associated complications.
📊
Key Findings & Data:MATERIAL and METHODS: A retrospective charts review was done over a 10-year period at our institution.
💡
Conclusion & Impact:The overall rate of shunt failure was 14.9% at a mean follow-up of 16 months.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: Ventriculoperitoneal (VP) shunt insertion remains the most popular method for the treatment of hydrocephalus despite its associated complications. We assessed VP shunt survival in a group of patients who had developed hydrocephalus following cranial surgery. MATERIAL and METHODS: A retrospective charts review was done over a 10-year period at our institution. Kaplan-Meier survival curves and Log-Rank (Cox-Mantel) test were used to analyze various factors affecting VP shunt survival. RESULTS: Among the 67 cases included, a total of 28 (46.3%) patients had undergone cranial surgery for brain tumors. The overall rate of shunt failure was 14.9% at a mean follow-up of 16 months. Shunt failure in pediatric patients (20%) was slightly higher than that in adult patients (13.5%). The median time to first shunt failure was adversely influenced by a history of brain tumor (p = 0.019), prolonged antibiotic therapy (p = 0.018) and administration of steroids (p = 0.004). CONCLUSION: Shunt survival was worse in patients who developed hydrocephalus following cranial surgery performed for brain tumors and those who received either steroids or prolonged antibiotic therapy. Thus post-cranial surgery hydrocephalus represents a unique subset of hydrocephalus

🔖

Cite This Article

KHAN, F., REHMAN, A., SHAMIM, M. S., BARI, M. E. (2016). Ventriculoperitoneal (VP) Shunt Survival in Patients Developing Hydrocephalus After Cranial Surgery. Turkish Neurosurgery, Cilt: 26 - Sayı: 3, 369–377. https://ajindex.com/articles/404678

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Albright L, Reigel DH: Management of hydrocephalus secondary to posterior fossa tumors. J Neurosurg 46:52-55, 1977 2. Bebawy JF: Perioperative steroids for peritumoral intracranial edema: A review of mechanisms, efficacy and side effects. J Neurosurg Anesthesiol 24:173-177, 2012 3. Beni-Adani L, Biani N, Ben-Sirah L, Constantini S: The occurrence of obstructive vs absorptive hydrocephalus in newborns and infants: Relevance to treatment choices. Childs Nerv Syst 22:1543-1563, 2006 4. Buxton N, Macarthur D, Malluci C, Punt J, Vloeberghs M: Neuroendoscopic third ventriculostomy in patients less than 1 year old. Pediatr Neurosurg 29:73-76, 1998 5. Choksey MS, Malik IA: Zero tolerance to shunt infections: Can it be achieved? J Neurol Neurosurg Psychiatry 75:87-91, 2004 6. Cinalli G, Sainte-Rose C, Chumas P, Zerah M, Brunelle F, Lot G, Pierre-Kahn A, Renier D: Failure of third ventriculostomy in the treatment of aqueductal stenosis in children. J Neurosurg 90:448-454, 1999 7. Di Rocco C, Marchese E, Velardi F: A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991-1992 Education Committee of the ISPN. Childs Nerv Syst 10:321-327, 1994 8. Enger P, Svendsen F, Wester K: CSF shunt infections in children: Experiences from a population-based study. Acta Neurochir (Wien) 145:243-248, 2003 9. Fan-Harvard P, Nataha MC: Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866- 880, 1987 10. Foley KT, Junck HL: Progression of hydrocephalus during corticosteroid therapy for neurosarcoidosis. Postgrad Med J 65:481-484, 1989 11. Fukuhara T, Vorster SJ, Luciano MG: Risk factors for failure of endoscopic third ventriculostomy for obstructive hydrocephalus. Neurosurgery 46:1100-1111, 2000 12. Gathura E, Poenaru D, Bransford R, Albright AL: Outcomes of ventriculoperitoneal shunt insertion in Sub-Saharan Africa. J Neurosurg Pediatr 6:329-335, 2010 13. Ghritlaharey RK, Budhwani KS, Shrivastava DK, Srivastava J: Ventriculoperitoneal shunt complications needing shunt revision in children: A review of 5 years of experience with 48 revisions. Afr J Pediatr Surg 9:32, 2012 14. Goldschmidt E, Hem S, Ajler P, Ielpi M, Loresi M, Giunta D, Carrizo A, Yampolsky C, Argibay P: A new model for dura mater healing: Human dural fibroblast culture. Neurol Res 35: 300-307, 2013 15. Goumnerova LC, Frim DM: Treatment of hydrocephalus with third ventriculocisternostomy: Outco